AzTrials
AzTrials

DementiaREACHNCT00177489

Coordinating Center for Caregiver Intervention Trial

A study testing multicomponent psychosocial intervention in people with Dementia and Alzheimer Disease, run by University of Pittsburgh at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary goal of this study is to test a single multi-component intervention among family caregivers of persons with Alzheimer's disease or related disorders. The overall objectives of study are to 1) identify and reduce modifiable risk factors among diverse family caregivers of patients with Alzheimer's Disease or… Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Dementia, Alzheimer Disease
What is being tested?
multicomponent psychosocial intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
613 participants
Where
5 sitesUnited States
Study dates
Jun 2002to Sep 2005
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age: 21 years or older
  • Family member of the care recipient
  • Must live with care recipient or share cooking facilities
  • Must have a telephone that will enable use of CTIS (Computer Telephone Integration System) system
  • Must plan to remain in the recruitment area for the duration of the intervention and follow-up
  • Caregiver role for more than 6 months
Show all 9Show fewer
  • Must provide on average 4 hours of supervision or direct assistance per day for the care recipient
  • Risk Screening Tool: must have a total score of at least 1 for questions 1-3, and a total of at least 2 for questions 4-9
  • NINCDS (MD diagnosis) of dementia or cognitive impairment (raw score on MMSE of 23 or less)

Who cannot join

  • Non-English, non-Spanish speaking
  • Active treatment (chemotherapy, radiation therapy) for cancer
  • Imminent placement of care recipient into a nursing home or with another caregiver (within 6 months)
  • Involvement in another clinical trial for caregivers
  • Participant in REACH I study
  • SPMSQ:> or = 4 errors*
Show all 18Show fewer
  • If the caregiver has been inconsistent with answers or repeated answers during the screening process, then the interviewer administers the Short Portable Mental Status Questionnaire (SPMSQ). If the caregiver missed 4 or more questions, he/she was excluded from the study.
  • Care Recipient Inclusion/Exclusion Criteria
  • Non-English, non-Spanish speaking
  • History of Parkinson's Disease or a stroke with no reported decline in memory over the past year
  • Active treatment (chemotherapy, radiation therapy) for cancer
  • More than three acute medical hospitalizations in past year (other than psychiatric or Alzheimer's Disease related admission)
  • Schizophrenia (onset of delusions before age 45) or other severe mental illness
  • Dementia secondary to head trauma (probable)
  • Blindness or deafness if either disability prohibits them from completion of data collection or participation in the interventions
  • MMSE = 0 and Bedbound (confined to a bed or chair for >22 hours per day, for at least 4 of the past 7 days)
  • Planned nursing home admission in 6 months
  • Participant in REACH I study

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294-2041

  • University of Tennessee Health Science Center

    Memphis, Tennessee, 38163

  • Stanford University and Veterans Affairs

    Menlo Park, California, 94025

  • University of Miami at Miami, Center on Adult Development and Aging

    Miami, Florida, 33136

  • Thomas Jefferson University at Philadelphia, Center for Applied Research on Aging and Health

    Philadelphia, Pennsylvania, 19107

Other trials in United States

About this study

Official title: Coordinating Center for Multisite Intervention Trial for Diverse Caregivers

The primary goal of this study is to test a single multi-component intervention among family caregivers of persons with Alzheimer's disease or related disorders. The overall objectives of study are to 1) identify and reduce modifiable risk factors among diverse family caregivers of patients with Alzheimer's Disease or a related disorder, 2) enhance the quality of care of the care recipients, and 3) enhance the well-being of the caregivers.

Read the detailed description

The proposed Coordinating Center (CC) will work with five sites and staff from the National Institute on Aging (NIA) and the National Institute of Nursing Research (NINR) to implement a multi-site caregiver intervention trial. The overall objective of this research program is to refine and test a multicomponent psychosocial intervention to reduce burden and depression among family caregivers of persons with Alzheimer's Disease or a related disorder. This competing renewal will build upon results obtained from its parent multi-site feasibility study, Resources for Enhancing Alzheimer's Caregiver Health (REACH) funded by the NIA/NINR as a cooperative agreement (UO1-AG13305). In the study proposed here, five intervention sites (Birmingham, Memphis, Miami, Palo Alto, and Philadelphia) will recruit 600 (120 per site) caregiver-care recipient dyads consisting of equal numbers of African Americans/Blacks, Hispanics/Latinos, and Caucasians/Whites. Caregivers will be randomized to either an in-home multicomponent intervention condition or a standardized information-only control condition.

The Coordinating Center at the University of Pittsburgh will work with the intervention site investigators and the NIA/NINR to support the implementation of the intervention study at each site and to collect and analyze a common database across sites.

Being tested
multicomponent psychosocial intervention, Control arm
Keywords
Family Caregivers, Dementia, Alzheimer Disease, Randomized Controlled Trial, Intervention Studies
Medical subject headings
Dementia, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • multicomponent psychosocial interventionBehavioural

    The intervention addressed caregiver depression, burden, self-care, and social support and care recipient problem behaviors through 12 in-home and telephone sessions over 6 months.

  • Control armOther

    Caregivers in the control group received 2 brief "check-in" telephone calls during the 6-month intervention.

Study groups in NCT00177489
Study groupRoleWhat they receive
TreatmentExperimentalThe intervention addressed caregiver depression, burden, self-care, and social support and care recipient problem behaviors through 12 in-home and telephone sessions over 6 months.
Receives: Behavioral: multicomponent psychosocial intervention
ControlOtherCaregivers in the control group received 2 brief "check-in" telphone calls during the 6 month intervention.
Receives: Other: Control arm

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. multivariate quality of life indicator- assessed caregiver burden, depressive symptoms, self-care, social support and patient problem behaviors. Assessed at six months post-randomization.

    Measured: six months

Secondary outcomes (1)
  1. Caregiver clinical depression and patient institutional placement-six months post-randomization.

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2005 (estimated)
  2. Study startJun 2002
  3. Primary completionSep 2005
  4. Study completionSep 2005

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
613 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00177489
Sponsor's protocol ID
AG13305
Acronym
REACH
Status last verified
Jan 2016
First submitted
12 Sep 2005
Last updated
5 Jan 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: There is no plan to make individual participant data available.

Publications

  • Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher-Thompson D, Gitlin LN, Klinger J, Koepke KM, Lee CC, Martindale-Adams J, Nichols L, Schulz R, Stahl S, Stevens A, Winter L, Zhang S; Resources for Enhancing Alzheimer's Caregiver Health (REACH) II Investigators. Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med. 2006 Nov 21;145(10):727-38. doi: 10.7326/0003-4819-145-10-200611210-00005.

    PubMed 17116917
  • Nichols LO, Martindale-Adams J, Burns R, Graney MJ, Zuber J. Typical and atypical dementia family caregivers: systematic and objective comparisons. Int J Aging Hum Dev. 2011;72(1):27-43. doi: 10.2190/AG.72.1.b.

    PubMed 21391405
  • Elliott AF, Burgio LD, Decoster J. Enhancing caregiver health: findings from the resources for enhancing Alzheimer's caregiver health II intervention. J Am Geriatr Soc. 2010 Jan;58(1):30-7. doi: 10.1111/j.1532-5415.2009.02631.x.

    PubMed 20122038

Questions about this trial

What is this clinical trial studying?

A study testing multicomponent psychosocial intervention in people with Dementia and Alzheimer Disease, run by University of Pittsburgh at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

multivariate quality of life indicator- assessed caregiver burden, depressive symptoms, self-care, social support and patient problem behaviors. Assessed at six months post-randomization. (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00177489, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2016; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in